title: Afrezza inhaled insulin: the fastest-acting FDA-approved insulin on the market has favorable properties.
authors.affiliation: Mills-Peninsula Health Services, San Mateo, CA, USA dklonoff@diabetestechnology.org.
authors.forename: David C
authors.initials: DC
authors.lastname: Klonoff
mesh_terms: D000280:Administration, Inhalation; D003920:Diabetes Mellitus / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007328:Insulin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin
keywords: Afrezza; diabetes; inhaled insulin; pulmonary